Tapewire

NYSE · USD

ENVA

Enova International, Inc.

Export transactions ↓
Tapewire entity
3836
SEC CIK
0001529864
Parsed reports
520

Last 12 months

Inside the activity.

0 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202501
Jan 202605
Feb 202605
Mar 202600
Apr 202602
May 202605
Jun 202604
Jul 202602
Aug 202602
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 17, 2026 Filed Sep 21, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 20,750 $0.00 Strike: $20.73 $0.00
Disclosure

SEC source: 0001193125-26-396711 · ownership.xml · derivative · entry 3

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,363

Underlying: Common stock; par value $0.00001 per share · 20,750 shares

Expires 2027-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.

Read SEC document
September 17, 2026 Filed Sep 21, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
SaleCommon stock, par value $0.00001 per share 20,750 $178.24 $3,698,432.28
Disclosure

SEC source: 0001193125-26-396711 · ownership.xml · nonDerivative · entry 2

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 306,444

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on January 30, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $174.55 to $180.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

Read SEC document
September 17, 2026 Filed Sep 21, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionCommon stock, par value $0.00001 per share 20,750 $20.73 $430,147.50
Disclosure

SEC source: 0001193125-26-396711 · ownership.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 327,194

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 26, 2026 Filed Aug 27, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 9,078 $0.00 Strike: $20.73 $0.00
Disclosure

SEC source: 0001193125-26-371385 · ownership.xml · derivative · entry 6

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 166,113

Underlying: Common stock; par value $0.00001 per share · 9,078 shares

Expires 2027-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F5 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F6 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.

Read SEC document
August 26, 2026 Filed Aug 27, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
SaleCommon stock, par value $0.00001 per share 9,078 $239.16 $2,171,122.62
Disclosure

SEC source: 0001193125-26-371385 · ownership.xml · nonDerivative · entry 4

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 306,444

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on January 30, 2026.

F3 · price: This transaction was executed in multiple trades at prices ranging from $236.29 to $244.93. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

Read SEC document
August 26, 2026 Filed Aug 27, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionCommon stock, par value $0.00001 per share 9,078 $20.73 $188,186.94
Disclosure

SEC source: 0001193125-26-371385 · ownership.xml · nonDerivative · entry 3

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 315,522

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 25, 2026 Filed Aug 27, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 9,491 $0.00 Strike: $20.73 $0.00
Disclosure

SEC source: 0001193125-26-371385 · ownership.xml · derivative · entry 5

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 175,191

Underlying: Common stock; par value $0.00001 per share · 9,491 shares

Expires 2027-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F5 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F6 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.

Read SEC document
August 25, 2026 Filed Aug 27, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
SaleCommon stock, par value $0.00001 per share 9,491 $244.01 $2,315,902.71
Disclosure

SEC source: 0001193125-26-371385 · ownership.xml · nonDerivative · entry 2

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 306,444

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on January 30, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $241.46 to $251.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

Read SEC document
August 25, 2026 Filed Aug 27, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionCommon stock, par value $0.00001 per share 9,491 $20.73 $196,748.43
Disclosure

SEC source: 0001193125-26-371385 · ownership.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 315,935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 05, 2026 Filed Aug 7, 2026 20:30 UTC
Veltre MariaDirector
GrantCommon stock, par value $0.00001 per share 772 $0.00 $0.00
Disclosure

SEC source: 0001752243-26-000006 · ownership.xml · nonDerivative · entry 1

Veltre Maria · CIK 0001752243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 772

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on August 5, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
August 05, 2026 Filed Aug 7, 2026 20:30 UTC
Chartier KirkChief Strategy Officer
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 2,095 $0.00 Strike: $257.79 $0.00
Disclosure

SEC source: 0001483333-26-000002 · ownership.xml · derivative · entry 1

Chartier Kirk · CIK 0001483333 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,095

Underlying: Common stock; par value $0.00001 per share · 2,095 shares

Expires 2033-08-05

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029.

Read SEC document
August 05, 2026 Filed Aug 7, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 6,190 $0.00 Strike: $257.79 $0.00
Disclosure

SEC source: 0001315224-26-000004 · ownership.xml · derivative · entry 1

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,190

Underlying: Common stock; par value $0.00001 per share · 6,190 shares

Expires 2033-08-05

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029.

Read SEC document
August 05, 2026 Filed Aug 7, 2026 20:30 UTC
Rahilly SeanGeneral Counsel and Secretary
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 1,453 $0.00 Strike: $257.79 $0.00
Disclosure

SEC source: 0001621195-26-000002 · ownership.xml · derivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,453

Underlying: Common stock; par value $0.00001 per share · 1,453 shares

Expires 2033-08-05

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029.

Read SEC document
August 05, 2026 Filed Aug 7, 2026 20:30 UTC
Cunningham Steven EDirector · Chief Executive Officer
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 7,359 $0.00 Strike: $257.79 $0.00
Disclosure

SEC source: 0001575452-26-000002 · ownership.xml · derivative · entry 1

Cunningham Steven E · CIK 0001575452 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,359

Underlying: Common stock; par value $0.00001 per share · 7,359 shares

Expires 2033-08-05

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029.

Read SEC document
August 05, 2026 Filed Aug 7, 2026 20:30 UTC
Cornelis ScottChief Financial Officer
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 1,500 $0.00 Strike: $257.79 $0.00
Disclosure

SEC source: 0002104070-26-000005 · ownership.xml · derivative · entry 1

Cornelis Scott · CIK 0002104070 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common stock; par value $0.00001 per share · 1,500 shares

Expires 2033-08-05

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029.

Read SEC document
July 15, 2026 Filed Jul 16, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 11,494 $0.00 Strike: $20.73 $0.00
Disclosure

SEC source: 0001315224-26-000002 · ownership.xml · derivative · entry 6

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 184,682

Underlying: Common stock; par value $0.00001 per share · 11,494 shares

Expires 2027-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.

Read SEC document
July 15, 2026 Filed Jul 16, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
SaleCommon stock, par value $0.00001 per share 11,494 $231.45 $2,660,332.28
Disclosure

SEC source: 0001315224-26-000002 · ownership.xml · nonDerivative · entry 4

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 306,444

F2 · price: This transaction was executed in multiple trades at prices ranging from $225.64 to $235.4298. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

Read SEC document
July 15, 2026 Filed Jul 16, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionCommon stock, par value $0.00001 per share 11,494 $20.73 $238,270.62
Disclosure

SEC source: 0001315224-26-000002 · ownership.xml · nonDerivative · entry 3

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 317,938

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 14, 2026 Filed Jul 16, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 17,006 $0.00 Strike: $20.73 $0.00
Disclosure

SEC source: 0001315224-26-000002 · ownership.xml · derivative · entry 5

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 196,176

Underlying: Common stock; par value $0.00001 per share · 17,006 shares

Expires 2027-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.

Read SEC document
July 14, 2026 Filed Jul 16, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
SaleCommon stock, par value $0.00001 per share 17,006 $231.51 $3,936,992.74
Disclosure

SEC source: 0001315224-26-000002 · ownership.xml · nonDerivative · entry 2

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 306,444

F1 · price: This transaction was executed in multiple trades at prices ranging from $229.9452 to $233.6532. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

Read SEC document
July 14, 2026 Filed Jul 16, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionCommon stock, par value $0.00001 per share 17,006 $20.73 $352,534.38
Disclosure

SEC source: 0001315224-26-000002 · ownership.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 323,450

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 20:30 UTC
TEBBE MARKDirector
SaleCommon stock, par value $0.00001 per share 20,000 $201.37 $4,027,360.00
Disclosure

SEC source: 0001193125-26-279537 · ownership.xml · nonDerivative · entry 1

TEBBE MARK · CIK 0001131785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,029

F1 · price: This transaction was executed in multiple trades at prices ranging from $200.325 to $202.26. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

Read SEC document
June 17, 2026 Filed Jun 22, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 33,060 $0.00 Strike: $20.73 $0.00
Disclosure

SEC source: 0001193125-26-277580 · ownership.xml · derivative · entry 3

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,182

Underlying: Common stock; par value $0.00001 per share · 33,060 shares

Expires 2027-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F4 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.

Read SEC document
June 17, 2026 Filed Jun 22, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
SaleCommon stock, par value $0.00001 per share 33,060 $199.05 $6,580,639.28
Disclosure

SEC source: 0001193125-26-277580 · ownership.xml · nonDerivative · entry 2

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 306,444

F1 · price: This transaction was executed in multiple trades at prices ranging from $193.85 to $202.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

Read SEC document
June 17, 2026 Filed Jun 22, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionCommon stock, par value $0.00001 per share 33,060 $20.73 $685,333.80
Disclosure

SEC source: 0001193125-26-277580 · ownership.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 339,504

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 16, 2026 Filed Jun 16, 2026 20:30 UTC SaleCommon stock, par value $0.00001 per share 3,500 $188.02 $658,054.95
Disclosure

SEC source: 0001193125-26-272696 · ownership.xml · nonDerivative · entry 2

GOODYEAR WILLIAM M · CIK 0001115909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,820

F1 · price: This transaction was executed in multiple trades at prices ranging from $186.53 to $190.17. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 20:30 UTC GiftCommon stock, par value $0.00001 per share 8,437 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-272696 · ownership.xml · nonDerivative · entry 1

GOODYEAR WILLIAM M · CIK 0001115909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,320

Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:30 UTC SaleCommon stock, par value $0.00001 per share 5,983 $163.13 $975,999.01
Disclosure

SEC source: 0001193125-26-255557 · ownership.xml · nonDerivative · entry 1

GOODYEAR WILLIAM M · CIK 0001115909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,757

F1 · price: This transaction was executed in multiple trades at prices ranging from $161.28 to $164.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

Read SEC document
May 29, 2026 Filed Jun 2, 2026 20:30 UTC SaleCommon stock, par value $0.00001 per share 1,300 $161.20 $209,555.84
Disclosure

SEC source: 0001193125-26-253599 · ownership.xml · nonDerivative · entry 1

RICE LINDA JOHNSON · CIK 0001188735 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,277

F1 · price: This transaction was executed in multiple trades at prices ranging from $161.1102 to $161.47. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

Read SEC document
May 22, 2026 Filed May 26, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 3,076 $0.00 Strike: $20.73 $0.00
Disclosure

SEC source: 0001193125-26-239437 · ownership.xml · derivative · entry 6

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 246,242

Underlying: Common stock; par value $0.00001 per share · 3,076 shares

Expires 2027-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.

Read SEC document
May 22, 2026 Filed May 26, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
SaleCommon stock, par value $0.00001 per share 3,076 $158.45 $487,382.05
Disclosure

SEC source: 0001193125-26-239437 · ownership.xml · nonDerivative · entry 4

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 306,444

F2 · price: This transaction was executed in multiple trades at prices ranging from $157.50 to $161.24. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

Read SEC document
May 22, 2026 Filed May 26, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionCommon stock, par value $0.00001 per share 3,076 $20.73 $63,765.48
Disclosure

SEC source: 0001193125-26-239437 · ownership.xml · nonDerivative · entry 3

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 309,520

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 7,180 $0.00 Strike: $20.73 $0.00
Disclosure

SEC source: 0001193125-26-239437 · ownership.xml · derivative · entry 5

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 249,318

Underlying: Common stock; par value $0.00001 per share · 7,180 shares

Expires 2027-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
SaleCommon stock, par value $0.00001 per share 7,180 $160.37 $1,151,473.83
Disclosure

SEC source: 0001193125-26-239437 · ownership.xml · nonDerivative · entry 2

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 306,444

F1 · price: This transaction was executed in multiple trades at prices ranging from $158.16 to $162.90. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
Exercise / conversionCommon stock, par value $0.00001 per share 7,180 $20.73 $148,841.40
Disclosure

SEC source: 0001193125-26-239437 · ownership.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 313,624

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 18, 2026 Filed May 20, 2026 20:30 UTC SaleCommon stock, par value $0.00001 per share 6,231 $166.08 $1,034,829.53
Disclosure

SEC source: 0001193125-26-232704 · ownership.xml · nonDerivative · entry 1

GOODYEAR WILLIAM M · CIK 0001115909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,740

F1 · price: This transaction was executed in multiple trades at prices ranging from $165.60 to $167.235. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:30 UTC GrantCommon stock, par value $0.00001 per share 1,320 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-226923 · ownership.xml · nonDerivative · entry 1

CARNAHAN ELLEN · CIK 0001037175 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,704

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:30 UTC GrantCommon stock, par value $0.00001 per share 1,320 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-226943 · ownership.xml · nonDerivative · entry 1

GOODYEAR WILLIAM M · CIK 0001115909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,971

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:30 UTC
TEBBE MARKDirector
GrantCommon stock, par value $0.00001 per share 1,320 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-226933 · ownership.xml · nonDerivative · entry 1

TEBBE MARK · CIK 0001131785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,029

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:30 UTC
Chartier KirkChief Strategy Officer
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 3,038 $0.00 Strike: $166.88 $0.00
Disclosure

SEC source: 0001193125-26-226928 · ownership.xml · derivative · entry 1

Chartier Kirk · CIK 0001483333 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,038

Underlying: Common stock; par value $0.00001 per share · 3,038 shares

Expires 2033-05-13

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:30 UTC
McGowan MarkDirector
GrantCommon stock, par value $0.00001 per share 1,320 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-226940 · ownership.xml · nonDerivative · entry 1

McGowan Mark · CIK 0001482192 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,021

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:30 UTC GrantCommon stock, par value $0.00001 per share 1,320 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-226944 · ownership.xml · nonDerivative · entry 1

KAPLAN GREGG A. · CIK 0001461299 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,232

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:30 UTC GrantCommon stock, par value $0.00001 per share 1,320 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-226924 · ownership.xml · nonDerivative · entry 1

FEEHAN DANIEL R · CIK 0001188234 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,706

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:30 UTC GrantCommon stock, par value $0.00001 per share 1,320 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-226941 · ownership.xml · nonDerivative · entry 1

RICE LINDA JOHNSON · CIK 0001188735 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,577

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:30 UTC
Fisher DavidDirector · Executive Chairman
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 8,979 $0.00 Strike: $166.88 $0.00
Disclosure

SEC source: 0001193125-26-226934 · ownership.xml · derivative · entry 1

Fisher David · CIK 0001315224 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,979

Underlying: Common stock; par value $0.00001 per share · 8,979 shares

Expires 2033-05-13

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:30 UTC
Gray James ADirector
GrantCommon stock, par value $0.00001 per share 1,320 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-226945 · ownership.xml · nonDerivative · entry 1

Gray James A · CIK 0001315492 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,029

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:33 UTC
Cornelis ScottChief Financial Officer
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 2,176 $0.00 Strike: $166.88 $0.00
Disclosure

SEC source: 0001193125-26-226985 · ownership.xml · derivative · entry 2

Cornelis Scott · CIK 0002104070 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,176

Underlying: Common stock; par value $0.00001 per share · 2,176 shares

Expires 2033-05-13

F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:30 UTC GrantCommon stock, par value $0.00001 per share 1,320 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-226931 · ownership.xml · nonDerivative · entry 1

Corby Lindsay Y · CIK 0001557298 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,660

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:30 UTC
Cunningham Steven EDirector · Chief Executive Officer
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 10,674 $0.00 Strike: $166.88 $0.00
Disclosure

SEC source: 0001193125-26-226927 · ownership.xml · derivative · entry 1

Cunningham Steven E · CIK 0001575452 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,674

Underlying: Common stock; par value $0.00001 per share · 10,674 shares

Expires 2033-05-13

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:30 UTC
Rahilly SeanGeneral Counsel and Secretary
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative 2,108 $0.00 Strike: $166.88 $0.00
Disclosure

SEC source: 0001193125-26-226922 · ownership.xml · derivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,108

Underlying: Common stock; par value $0.00001 per share · 2,108 shares

Expires 2033-05-13

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.